• January 27, 2022

Tags : AuraVax

University of Houston, AuraVax Therapeutics partner for COVID-19 vaccine

On Monday, officials with the University of Houston announced that the school has entered into an exclusive license option agreement with AuraVax Therapeutics Inc., a Houston based biotech company developing novel vaccines to help patients defeat debilitating respiratory diseases such as COVID-19. Under terms of the agreement, AuraVax has the option to exclusively license a […]Read More